NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. Comparison Chart Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.72 CNY | -2.35% |
|
+0.96% | -8.53% |
| 13/05 | NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US | MT |
| 01/05 | NKFPharma Gets Nod to Register New Cancer Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. | Other Pharmaceuticals | -2.35% | +0.96% | -8.53% | -1.93% | +7.95% | 312.67Cr |  |  | |
